SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-21-015113
Filing Date
2021-04-30
Accepted
2021-04-30 12:50:10
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A nc10023577x2_defa14a.htm DEFA14A 17130
2 nc10023577x2_nc1.jpg GRAPHIC 1838793
3 nc10023577x2_nc2.jpg GRAPHIC 1267684
  Complete submission text file 0001140361-21-015113.txt   3994257
Mailing Address 385 OYSTER POINT BOULEVARD, SUITE 9A SOUTH SAN FRANCISCO CA 94080
Business Address 385 OYSTER POINT BOULEVARD, SUITE 9A SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-35285 | Film No.: 21875655
SIC: 2836 Biological Products, (No Diagnostic Substances)